Detalles de la búsqueda
1.
Barriers and Facilitators to Harm Reduction for Opioid Use Disorder: A Qualitative Study of People With Lived Experience.
Ann Emerg Med
; 83(4): 340-350, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38180403
2.
Patient experiences of methadone treatment changes during the first wave of COVID-19: a national community-driven survey.
Harm Reduct J
; 20(1): 31, 2023 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36894968
3.
The Methadone Manifesto: Treatment Experiences and Policy Recommendations From Methadone Patient Activists.
Am J Public Health
; 112(S2): S117-S122, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35349312
4.
Adoption of methadone take home policy by U.S. state opioid treatment authorities during COVID-19.
Int J Drug Policy
; 124: 104302, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38183861
5.
Methadone's Resurgence in Bridging the Treatment Gap in the Overdose Crisis: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use, and Addiction).
Subst Use Addctn J
; 45(3): 337-345, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38804606
6.
Rethinking urban-rural designations in public health surveillance of the overdose crisis and crafting an agenda for future monitoring.
Int J Drug Policy
; 118: 104072, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37327697
7.
"Just give them a choice": Patients' perspectives on starting medications for opioid use disorder in the ED.
Acad Emerg Med
; 29(8): 928-943, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35426962
8.
We are the researched, the researchers, and the discounted: The experiences of drug user activists as researchers.
Int J Drug Policy
; 98: 103364, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34294521
Resultados
1 -
8
de 8
1
Próxima >
>>